Anne Valade

585 total citations
19 papers, 433 citations indexed

About

Anne Valade is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Anne Valade has authored 19 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Psychiatry and Mental health. Recurrent topics in Anne Valade's work include Neuroscience and Neuropharmacology Research (8 papers), Epilepsy research and treatment (7 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Anne Valade is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Epilepsy research and treatment (7 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Anne Valade collaborates with scholars based in Belgium, United Kingdom and United States. Anne Valade's co-authors include Laurent Provins, Joël Mercier, Adrian Hall, Dominique Urban, Jean‐Marie Beau, Tim Buchanan, Alain Plenevaux, Éric Salmon, André Luxen and Nathalie Mestdagh and has published in prestigious journals such as Nature Communications, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Anne Valade

18 papers receiving 425 citations

Peers

Anne Valade
Richard Pracitto United States
Caroline Papin United States
Loan Miller United States
Erika A. Currier United States
Dhruva D. Dhavale United States
Anne Valade
Citations per year, relative to Anne Valade Anne Valade (= 1×) peers Florian Montel

Countries citing papers authored by Anne Valade

Since Specialization
Citations

This map shows the geographic impact of Anne Valade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Valade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Valade more than expected).

Fields of papers citing papers by Anne Valade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Valade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Valade. The network helps show where Anne Valade may publish in the future.

Co-authorship network of co-authors of Anne Valade

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Valade. A scholar is included among the top collaborators of Anne Valade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Valade. Anne Valade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hall, Adrian, Jan Abendroth, Tom Ceska, et al.. (2022). Discovery and Characterization of a Novel Series of Chloropyrimidines as Covalent Inhibitors of the Kinase MSK1. ACS Medicinal Chemistry Letters. 13(7). 1099–1108. 7 indexed citations
2.
Sun, Bingfa, Dan Feng, Matthew Ling-Hon Chu, et al.. (2021). Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist. Nature Communications. 12(1). 3305–3305. 37 indexed citations
4.
Sintim, Herman O., et al.. (2019). Squarate desymmetrisation–ozonolysis as an approach to β-substituted-α-ketosuccinates and squalestatin synthesis. Tetrahedron. 75(50). 130747–130747. 2 indexed citations
5.
Hall, Adrian, Laurent Provins, & Anne Valade. (2018). Novel Strategies To Activate the Dopamine D1 Receptor: Recent Advances in Orthosteric Agonism and Positive Allosteric Modulation. Journal of Medicinal Chemistry. 62(1). 128–140. 46 indexed citations
6.
Mamari, Hamad H. Al, et al.. (2018). Alkene protection against acid using a bromide substituent: application in a total synthesis of (−)-6,7-dideoxysqualestatin H5. Chemical Communications. 54(42). 5354–5356. 6 indexed citations
7.
Bahri, Mohamed Ali, Alain Plenevaux, Joël Aerts, et al.. (2017). Measuring brain synaptic vesicle protein 2A with positron emission tomography and [ 18 F]UCB‐H. Alzheimer s & Dementia Translational Research & Clinical Interventions. 3(4). 481–486. 47 indexed citations
8.
Mercier, Joël, Laurent Provins, & Anne Valade. (2017). Discovery and development of SV2A PET tracers: Potential for imaging synaptic density and clinical applications. Drug Discovery Today Technologies. 25. 45–52. 38 indexed citations
9.
Warnock, Geoffrey, Joël Aerts, Mohamed Ali Bahri, et al.. (2014). Evaluation of18F-UCB-H as a Novel PET Tracer for Synaptic Vesicle Protein 2A in the Brain. Journal of Nuclear Medicine. 55(8). 1336–1341. 64 indexed citations
11.
Warnock, Geoffrey, Mohamed Ali Bahri, Joël Aerts, et al.. (2013). Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H. EJNMMI Research. 3(1). 35–35. 34 indexed citations
12.
Provins, Laurent, Sylvain Célanire, B. Christophe, et al.. (2012). Lead Optimization of Thiazolo[5,4‐c]piperidines: 3‐Cyclobutoxy Linker as a Key Spacer for H3R Inverse Agonists. ChemMedChem. 7(12). 2087–2092. 2 indexed citations
13.
Warnock, Geoffrey, Joël Aerts, Mohamed Ali Bahri, et al.. (2012). CHARACTERIZATION OF A NOVEL RADIOTRACER TARGETING SYNAPTIC VESICLE PROTEIN 2A (SV2A). Open Repository and Bibliography (University of Liège). 1 indexed citations
14.
Ryck, Marc De, et al.. (2011). Defining the Structural Parameters That Confer Anticonvulsant Activity by the Site-by-Site Modification of (R)-N′-Benzyl 2-Amino-3-methylbutanamide. Journal of Medicinal Chemistry. 54(19). 6432–6442. 9 indexed citations
15.
Valade, Anne, Claire Brown, Eric Detrait, et al.. (2011). Discovery of novel selective Sigma-1 ligands as cognitive enhancers. MedChemComm. 2(7). 655–660. 6 indexed citations
16.
Salomé, Christophe, et al.. (2011). Primary Amino Acid Derivatives: Compounds with Anticonvulsant and Neuropathic Pain Protection Activities. Journal of Medicinal Chemistry. 54(13). 4815–4830. 24 indexed citations
18.
Valade, Anne, Dominique Urban, & Jean‐Marie Beau. (2006). Target‐Assisted Selection of Galactosyltransferase Binders from Dynamic Combinatorial Libraries. An Unexpected Solution with Restricted Amounts of the Enzyme. ChemBioChem. 7(7). 1023–1027. 30 indexed citations
19.
Valade, Anne, Dominique Urban, & Jean‐Marie Beau. (2006). Two Galactosyltransferases' Selection of Different Binders from the Same Uridine-Based Dynamic Combinatorial Library. Journal of Combinatorial Chemistry. 9(1). 1–4. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026